The IPECAD conferences are unique by exclusively addressing issues related to economic evaluation of drug treatments for Alzheimer’s disease, bringing together leading experts and opinion leaders from academia, technology assessment agencies, regulatory bodies, patient associations and the pharmaceutical industry.
Some of the key topics that have been addressed at the conferences include:
- Economic and humanistic burden of Alzheimer’s disease
- Modeling disease progression and predicting long term outcomes
- The role of real world evidence in demonstrating the value of therapies for Alzheimer’s disease
- Identifying patients with early AD and measuring disease progression in a way that is meaningful to stakeholders
- Identifying policy challenges and potential solutions relating to the introduction of novel treatments for Alzheimer’s disease
Overview of previous conferences.
List of organizors and scientific committee.